“wrf-capital” Archives

Entry Author Date Location
Accelerator Adds $11.7M, Reels in AbbVie, WuxiTech to Back Startups 09/29/15 Seattle
With New CEO, Seattle’s Faraday Pharma Aims to Exploit Ikaria Roots 09/03/15 Seattle
To Take On New York, Accelerator Makes Big Changes 08/14/14 New York
East Coast Biotech Roundup: Emulate, Accelerator, Retrophin, & More 08/01/14 Boston
Accelerator Bags $51M, Makes Long-Awaited Move to NYC 07/29/14 New York
Stuck on Website ‘Help Island’? First UW iSchool Spinout Has the Answer 05/23/14 Seattle
SNUPI Technologies Raises $7.5M from WRF, Madrona to Take Wally to Market 01/13/14 Seattle
Roundup: DreamBox, Resolution Tube, & Qazzow Funded; U District Startups 12/19/13 Seattle
Qazzow Obtains $2,400,000 Series A Financing 12/17/13 Seattle
Don’t Be Naïve: 7 Things to Know Before Taking a Biotech Startup Job 09/16/13 National
MicroGREEN Raises $10M From Increasingly Active Tribal Investors 08/29/13 Seattle
VLST, After Nine Years and $50M, Sells Assets and Winds Down 08/07/13 Seattle
UW Spinout Cardiac Insight Wins FDA OK for Heartbeat Monitor 06/06/13 Seattle
Mobisante Grabs $4.2M for Mobile Ultrasound Tools 06/05/13 Seattle
Mirador Biomedical Study: Spend $35 on Our Device & Save $116 05/29/13 Seattle
Cardeas Pharma Secures $34,000,000 Series B Funding Round 05/23/13 Seattle
Cardeas Pharma Snags $34M For Antibiotic Against Hospital Infections 05/22/13 Seattle
UW Spinoff Resolve Therapeutics Lures In Takeda, Lines Up Return 02/27/13 Seattle
Roundup: 9Mile, Invoke, nFluence, FlexMinder, Sigby, and Globys 01/31/13 National
FlexMinder Receives $1,400,000 New Financing Round 01/31/13 Seattle
The Fiscal Cliff Is Forcing a Biomedical Day of Reckoning 12/31/12 National
UW Spinoff Resolve Therapeutics Snags $5.8M for Lupus Drug 11/01/12 Seattle
Resolve Therapeutics Obtains $5,800,000 Series B Round 11/01/12 Seattle
Who Will Survive the Biotech VC Downturn? The Young and the Proven 10/22/12 National
VLST Cuts Scientific Group As Focus Shifts to Clinical Trials 09/27/12 Seattle
Accelerator Looks to Expand, With an Eye on the Big Apple 06/01/12 Seattle
Alder Biopharma Snags $38M To Charge Ahead With Antibody Drugs 04/19/12 Seattle
Alder Biopharmaceuticals Receives $38,000,000 Series D Financing Round 04/19/12 Seattle
Join Kevin Starr, Corey Goodman, Carl Weissman & More in Seattle April 3 01/19/12 Seattle
Mirador Biomedical Gets FDA Green Light to Expand Use of Digital Sensor 01/05/12 Seattle
Page 1 of 5 next page »